Endava Ltd. DAVA 深 沪
等待开盘 04-01 09:30:00 美东时间
4.42
+0.050
+1.14%
华盛通- 最 高4.55
- 今 开4.45
- 成交量 25.14万股
- 最 低 4.35
- 昨 收 4.37
- 总市值 2.34亿
- 52周最高 21.81
- 市盈率 静 9.48
- 换手率 0.48%
- 52周最低 4.21
- 委 比 -60.00%
- 总股本 5284.27万
- 历史最高 172.41
- 量 比 0.93
- 振 幅 4.58%
- 历史最低 4.21
- 每 手 1
- 风险率 4.69%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 潜在涨幅214.14%！HC Wainwright & Co.：Ardelyx获机构升目标价至18美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Ardelyx"买入"评级，目标价从10美元升至18美元；Truist Securities：维持Praxis Precision Medicine"买入"评级，目标价从500美元升至700美元
02-23 08:56
JP Morgan Maintains Neutral on Endava, Lowers Price Target to $9
JP Morgan analyst Puneet Jain maintains Endava (NYSE:DAVA) with a Neutral and lowers the price target from $10 to $9.
02-21 03:45
美股大行评级 | 潜在涨幅108.69%！Stephens & Co.维持圣玛丽石油勘测"超配"评级，上调目标价至49美元
今日重点评级关注：Stephens & Co.：维持圣玛丽石油勘测"超配"评级，目标价从48美元升至49美元；花旗：维持IDEAYA Biosciences"买入"评级，目标价从64美元升至65美元
02-20 15:57
Endava Narrows FY2026 Adj EPS Guidance from USD$1.08-$1.19 to $1.10-$1.18 vs $0.40 Est; Raises FY2026 Sales Guidance from $992.267M-$1.014B to $1.008B-$1.028B vs $968.410M Est
Endava (NYSE:DAVA) narrows FY2026 Adj EPS guidance from $1.08-$1.19 to $1.10-$1.18 vs $0.40 analyst estimate. Raises FY2026 sales outlook from $992.267 million-$1.014 billion to $1.008 billion-$1.028 billion vs $968.410
02-19 20:29
Endava Q2 Earnings Report: What Investors Need to Know
Endava (NYSE:DAVA) released its Q2 earnings on Thursday, February 19, 2026 at 0...
02-19 20:28
Endava Q2 Adj. EPS $0.21 Beats $0.05 Estimate, Sales $244.868M Beat $236.350M Estimate
Endava (NYSE:DAVA) reported quarterly earnings of $0.21 per share which beat the analyst consensus estimate of $0.05 by 320 percent. This is a 45.45 percent decrease over earnings of $0.39 per share from the same period
02-19 20:26
Earnings Scheduled For February 19, 2026
Companies Reporting Before The Bell • Deere (NYSE:DE) is expected to report qua...
02-19 19:11
Guggenheim Maintains Buy on Endava, Lowers Price Target to $13
Guggenheim analyst Jonathan Lee maintains Endava (NYSE:DAVA) with a Buy and lowers the price target from $15 to $13.
02-13 21:02
PayNet And NETS JV Awarded Contract To Be Nexus Technical Operator, With Support From Endava And AWS
Nexus Global Payments (NGP) appoints Payments Network Malaysia (PayNet) and Network for Electronic Transfers Singapore (NETS) joint venture as the Nexus Technical Operator (NTO). This follows a competitive procurement
02-09 19:28
美股大行评级 | 思科、On Holding、派拓网络等获多家机构上调目标价；Circle 遭富国、德银等多家机构下调目标价
今日重点评级关注：HC Wainwright & Co.：维持PDS Biotechnology"买入"评级，目标价从13美元升至15美元；HC Wainwright & Co.：维持PepGen Inc."买入"评级，目标价从18美元升至20美元
2025-11-14 10:43
